For media and shareholder inquiries:
Kyahn Williamson Buchan Consulting P: +61 3 9866 4722 M: +61 (0) 401 018828
If you wish to send an email please use the form below
Your Name (required)
Your Email (required)
Subject
Your Message
Patrys’ Deoxymab 3E10 Patent Granted in the U.S.
Patrys Licenses Deoxymab 3E10 Nanoparticle IP
Finance Update
Deoxymab 3E10 Lead Candidate Confirmed
